What question did this study set out to answer?

This study aims to identify mutations in uveal melanoma that correlate with prognosis to improve patient outcomes.

February 8, 20260 citations

Mutations with prognostic value in uveal melanoma. Analytical study of variants detected by targeted NGS.

MPManuel Pérez-PérezHospital Quirónsalud Sagrado Corazón CSCarmen García de Sola-Llamas AAAlessandro AgostinoAgilent Technologies (Italy)

Key Points

This study aims to identify mutations in uveal melanoma that correlate with prognosis to improve patient outcomes.
Analyzed mutations in genes BAP1, CHEK2, DICER1, and SF3B1 using targeted NGS.
Evaluated the association of these mutations with patient prognosis.
Classified histologic subgroups based on mutation presence.
BAP1, CHEK2, and DICER1 mutations are linked to worse outcomes in uveal melanoma.
SF3B1 mutations indicate a distinct histologic subgroup.
Routine mutational profiling can enhance risk stratification and patient monitoring.

Abstract

Mutations in BAP1, CHEK2, and DICER1 are independently associated with poorer prognosis in UM, while SF3B1 defines a distinct histologic subgroup. Routine mutational profiling by targeted NGS may aid in risk stratification and follow-up of UM patients.

KI fragen

Bookmark

View Full Paper